Meeting Highlights
Miami, March 27, 2009
Maui, January 14-17, 2009
San Francisco, October 24-29, 2008
Paris, June 11-14, 2008
Chicago, April 10, 2008
San Francisco, March 5-9, 2008
Affiliations
BioPharm Business News
Thursday, September 17, 2009
Lilly's Cymbalta Maintains Low Back Pain Relief
Data reported at a European pain meeting show that Cymbalta® (duloxetine) maintains relief of low back pain for 41 weeks...
Thursday, September 10, 2009
Lodotra Delayed-Release Prednisone Aces Phase III
Nitec Pharma's Lodotra™ delayed-release prednisone met phase III efficacy endpoints. Nitec expects to file for FDA approval in RA...
Tuesday, September 08, 2009
RA Drug Array ARRY-162 Fails in Phase 2
A new rheumatoid drug from Array BioPharma that modulates the MEK pathway did not meet Phase 2 efficacy goals...
Thursday, August 27, 2009
Lexicon Moves LX2931 Into RA Phase 2
Lexicon's LX2931 S1P lyase blocker is in Phase 2 trials in rheumatoid arthritis...
Thursday, August 20, 2009
Animal Rights Thugs Target Novartis CEO
Animal rights extremists desecrated the graves of pharma exec Daniel Vasella's mother and sister and are now suspected of an arson attack on his house...
Tuesday, August 04, 2009
FDA Spikes Pegloticase Gout OK
Savient Pharmaceuticals' shares tanked on the FDA's refusal to approve Krystexxa™ for gout...